Avoro Capital Advisors LLC Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$6858.2T
Holdings
36
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | UTHUNITED THERAPEUTICS CORP | 2,858,888 | $1024.5T | 14.94% | |
| 2 | ASNDASCENDIS PHARMA | 4,988,888 | $744.9T | 10.86% | |
| 3 | ARGXARGENX SE | 1,238,467 | $671.3T | 9.79% | |
| 4 | KRYSKRYSTAL BIOTECH INC | 2,622,222 | $477.3T | 6.96% | |
| 5 | MDGLMADRIGAL PHARMACEUTICALS INC | 2,029,000 | $430.6T | 6.28% | |
| 6 | APLSAPELLIS PHARMACEUTICALS INC. | 11,111,111 | $320.4T | 4.67% | |
| 7 | SRPTSAREPTA THERAPEUTICS INC | 2,555,555 | $319.2T | 4.65% | |
| 8 | RNAAVIDITY BIOSCIENCES INC | 6,875,000 | $315.8T | 4.60% | |
| 9 | AM6AMICUS THERAPEUTICS INC. | 23,175,000 | $247.5T | 3.61% | |
| 10 | ITCIEURINTRA-CELLULAR THERAPIES INC | 3,050,000 | $223.2T | 3.25% | |
| 11 | XENEXENON PHARMACEUTICALS INC | 5,666,666 | $223.1T | 3.25% | |
| 12 | KYMRKYMERA THERAPEUTICS INC | 4,500,000 | $213.0T | 3.11% | |
| 13 | VERAVERA THERAPEUTICS INC | 4,309,590 | $190.5T | 2.78% | |
| 14 | ARWRARROWHEAD PHARMACEUTICALS INC. | 8,888,888 | $172.2T | 2.51% | |
| 15 | BMRNBIOMARIN PHARMACEUTICAL INC | 2,038,015 | $143.3T | 2.09% | |
| 16 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 2,770,100 | $139.7T | 2.04% | |
| 17 | PCVXVAXCYTE INC | 1,175,000 | $134.3T | 1.96% | |
| 18 | SLNOSOLENO THERAPEUTICS INC | 2,181,000 | $110.1T | 1.61% | |
| 19 | BCRXBIOCRYST PHARMACEUTICALS INC | 11,865,000 | $90.2T | 1.31% | |
| 20 | SNDXSYNDAX PHARMACEUTICALS INC | 3,888,437 | $74.9T | 1.09% | |
| 21 | OCULOCULAR THERAPEUTIX INC | 8,060,000 | $70.1T | 1.02% | |
| 22 | KURAKURA ONCOLOGY INC | 3,541,505 | $69.2T | 1.01% | |
| 23 | MRUSMERUS N V | 1,355,000 | $67.7T | 0.99% | |
| 24 | TRMLTOURMALINE BIO INC | 2,222,222 | $57.1T | 0.83% | |
| 25 | MNKDMANNKIND CORP | 8,750,000 | $55.0T | 0.80% | |
| 26 | RAREULTRAGENYX PHARMACEUTICAL INC | 830,000 | $46.1T | 0.67% | |
| 27 | AUTLAUTOLUS THERAPEUTICS PLC | 12,345,678 | $44.8T | 0.65% | |
| 28 | IOVAIOVANCE BIOTHERAPEUTICS INC | 4,240,000 | $39.8T | 0.58% | |
| 29 | TSHATAYSHA GENE THERAPIES INC | 18,650,000 | $37.5T | 0.55% | |
| 30 | GLUEMONTE ROSA THERAPEUTICS INC | 5,790,236 | $30.7T | 0.45% | |
| 31 | CGONCG ONCOLOGY INC | 700,000 | $26.4T | 0.39% | |
| 32 | DYNDYNE THERAPEUTICS INC. | 650,000 | $23.3T | 0.34% | |
| 33 | SYRESPYRE THERAPEUTICS INC | 598,600 | $17.6T | 0.26% | |
| 34 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $5.9T | 0.09% | |
| 35 | NGNENEUROGENE INC | 22,029 | $924.3B | 0.01% | |
| 36 | INSMINSMED INC | 50,000 | $125.0B | 0.00% | Put |